M.G.H. van Oijen PhD publications

foto

Publications PhD M.G.H. van Oijen

Position
Associate Professor
Main activities
Research
Specialisation
Clinical Epidemiologist
Focus of research

Martijn van Oijen PhD is Evaluation of Cancer Care programleader of the Cancer Center Amsterdam. He is a principal investigator appointed as Associate Professor at the department of Medical Oncology at the Academic Medical Center (AMC), Amsterdam. His research group focuses on improving the quality of cancer care by forming and analyzing large datasets, combined with state of the art information technology, including decision support tools and wearable technology.

2021

  • Dijksterhuis Willemieke P M, Latenstein Anouk E J, van Kleef Jessy Joy, Verhoeven Rob H A, de Vries Jeanne H M, Slingerland Marije, Steenhagen Elles, Heisterkamp Joos, Timmermans Liesbeth M, de van der Schueren Marian A E, van Oijen Martijn G H, Beijer Sandra, van Laarhoven Hanneke W M Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study Journal of the National Comprehensive Cancer Network 2021:1-9 [PubMed]

2020

  • Belkouz A., Wilmink J. W., Haj Mohammad N., Hagendoorn J., de Vos-Geelen J., Dejong C. H. C., Homs M. Y. V., Groot Koerkamp B., van Gulik T. M., van Oijen M. G. H., Punt C. J. A., Klümpen H. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials Critical reviews in oncology/hematology 2020;151 [PubMed]
  • Latenstein Anouk E. J., Dijksterhuis Willemieke P. M., Mackay Tara M., Beijer Sandra, van Eijck Casper H. J., de Hingh Ignace H. J. T., Molenaar I. Quintus, van Oijen Martijn G. H., van Santvoort Hjalmar C., de van der Schueren Marian A. E., de Vos-Geelen Judith, de Vries Jeanne H. M., Wilmink Johanna W., Besselink Marc G., van Laarhoven Hanneke W. M. Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study Cancer medicine 2020;9 (24):9385-9395 [PubMed]
  • Bolhuis Karen, Kos Milan, van Oijen Martijn G. H., Swijnenburg Rutger-Jan, Punt Cornelis J. A. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review European journal of cancer (Oxford, England 2020;141:225-238 [PubMed]
  • Belkouz Ali, de Vos-Geelen Judith, Mathôt Ron A. A., Eskens Ferry A. L. M., van Gulik Thomas M., van Oijen Martijn G. H., Punt Cornelis J. A., Wilmink Johanna W., Klümpen Heinz-Josef Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial British journal of cancer 2020;122 (5):634-639 [PubMed]
  • Belkouz Ali, Nooijen Lynn E., Riady Hanae, Franken Lotte C., van Oijen Martijn G. H., Punt Cornelis J. A., Erdmann Joris I., Klümpen Heinz-Josef Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review Cancer treatment reviews 2020;91 [PubMed]
  • Kuiper Teaco, van Oijen M. G. H., van Velthuysen M. F., van Lelyveld N., van Leerdam M. E., Vleggaar F. D., Klümpen H. J. Endoscopically removed rectal NETs: a nationwide cohort study International journal of colorectal disease 2020 [PubMed]
  • Franken Mira D., de Hond Anne, Degeling Koen, Punt Cornelis J. A., Koopman Miriam, Uyl-de Groot Carin A., Versteegh Matthijs M., van Oijen Martijn G. H. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model Health and quality of life outcomes 2020;18 (1) [PubMed]
  • van Kleef J. J., van den Boorn H. G., Verhoeven R. H. A., Vanschoenbeek K., Abu-Hanna A., Zwinderman A. H., Sprangers M. A. G., van Oijen M. G. H., Schutter H. De, van Laarhoven H. W. M. External validation of the dutch SOURCE survival prediction model in belgian metastatic oesophageal and gastric cancer patients Cancers 2020;12 (4) [PubMed]
  • Dijksterhuis Willemieke P. M., Stroes Charlotte I., Tan Wan-Ling, Ithimakin Suthinee, Calles Antonio, van Oijen Martijn G. H., Verhoeven Rob H. A., Barriuso Jorge, Oosting Sjoukje F., Ivankovic Daniela Kolarevic, Furness Andrew J. S., Bozovic-Spasojevic Ivana, Gomez-Roca Carlos, van Laarhoven Hanneke W. M. From presentation to paper: Gender disparities in oncological research International journal of cancer. Journal international du cancer 2020;146 (11):3011-3021 [PubMed]
  • van den Ende Tom, Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Gastro-oesophageal junction: to FLOT or to CROSS? Acta oncologica (Stockholm, Sweden) 2020;59 (2):233-236 [PubMed]
  • Dijksterhuis Willemieke P. M., Verhoeven Rob H. A., Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V., van Voorthuizen Theo, Creemers Geert-Jan, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study International journal of cancer. Journal international du cancer 2020;146 (7):1889-1901 [PubMed]
  • Dijksterhuis Willemieke P. M., Verhoeven Rob H. A., Pape Marieke, Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V., van Voorthuizen Theo, Creemers Geert-Jan, Lemmens Valery E. P. P., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study European journal of cancer (Oxford, England 2020;139:107-118 [PubMed]
  • MacKay T. M., Smits F. J., Latenstein A. E. J., Bogte A., Bonsing B. A., Bos H., Bosscha K., Brosens L. A. A., Hol L., Busch O. R. C., Creemers G. J., Curvers W. L., den Dulk M., van Dieren S., van Driel L. M. J. W., Festen S., van Geenen E. J. M., van der Geest L. G., de Groot D. J. A., de Groot J. W. B., Haj Mohammad N., Haberkorn B. C. M., Haver J. T., van der Harst E., Hemmink G. J. M., de Hingh I. H., Hoge C., Homs M. Y. V., van Huijgevoort N. C., Jacobs M. A. J. M., Kerver E. D., Liem M. S. L., Los M., Lubbinge H., Luelmo S. A. C., de Meijer V. E., Mekenkamp L., Molenaar I. Q., van Oijen M. G. H., Patijn G. A., Quispel R., van Rijssen L. B., Römkens T. E. H., van Santvoort H. C., Schreinemakers J. M. J., Schut H., Seerden T., Stommel M. W. J., ten Tije A. J., Venneman N. G., Verdonk R. C., Verheij J., van Vilsteren F. G. I., de Vos-Geelen J., Vulink A., Wientjes C., Wit F., Wessels F. J., Zonderhuis B., van Werkhoven C. H., van Hooft J. E., van Eijck C. H. J., Wilmink J. W., van Laarhoven H. W. M., Besselink M. G. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): A multicenter stepped-wedge cluster randomized controlled trial Trials 2020;21 (1) [PubMed]
  • van den Berg I., van de Weerd S., Roodhart J. M. L., Vink G. R., van den Braak R. R. J. Coebergh, Jimenez C. R., Elias S. G., van Vliet D., Koelink M., Hong E., van Grevenstein W. M. U., van Oijen M. G. H., Beets-Tan R. G. H., van Krieken J. H. J. M., IJzermans J. N. M., Medema J. P., Koopman M. Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study BMC cancer 2020;20 (1):776 [PubMed]
  • Dijksterhuis Willemieke P. M., Verhoeven Rob H. A., Meijer Sybren L., Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V., van Voorthuizen Theo, Creemers Geert-Jan, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study Gastric cancer 2020;23 (4):579-590 [PubMed]
  • Jongeneel Gabrielle, Greuter Marjolein J. E., van Erning Felice N., Koopman Miriam, Medema Jan P., Kandimalla Raju, Goel Ajay, Bujanda Luis, Meijer Gerrit A., Fijneman Remond J. A., van Oijen Martijn G. H., Ijzermans Jan, Punt Cornelis J. A., Vink Geraldine R., Coupé Veerle M. H. Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) European journal of health economics : HEPAC 2020;21 (7):1059-1073 [PubMed]
  • Stroes Charlotte I., Schokker Sandor, Creemers Aafke, Molenaar Remco J., Hulshof Maarten C. C. M., van der Woude Stephanie O., Bennink Roel J., Mathôt Ron A. A., Krishnadath Kausilia K., Punt Cornelis J. A., Verhoeven Rob H. A., van Oijen Martijn G. H., Creemers Geert-Jan, Nieuwenhuijzen Grard A. P., van der Sangen Maurice J. C., Beerepoot Laurens V., Heisterkamp Joos, Los Maartje, Slingerland Marije, Cats Annemieke, Hospers Geke A. P., Bijlsma Maarten F., van Berge Henegouwen Mark I., Meijer Sybren L., van Laarhoven Hanneke W. M. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study Journal of clinical oncology 2020;38 (5):462-471 [PubMed]
  • Keikes Lotte, Koopman Miriam, Lemmens Valery E. P. P., VAN Oijen Martijn G. H., Punt Cornelis J. A. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study Anticancer research 2020;40 (8):4331-4341 [PubMed]
  • Keikes Lotte, Koopman Miriam, Stuiver Martijn M., Lemmens Valery E. P. P., van Oijen Martijn G. H., Punt Cornelis J. A. Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study Acta oncologica (Stockholm, Sweden) 2020;59 (4):395-403 [PubMed]
  • van den Ende Tom, van den Boorn H. ctor G., Hoonhout Nadine M., van Etten-Jamaludin Faridi S., Meijer Sybren L., Derks Sarah, de Gruijl Tanja D., Bijlsma Maarten F., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 2020;1874 (1) [PubMed]
  • van Kleef Jessy Joy, ter Veer Emil, van den Boorn H. ctor G., Schokker Sandor, Ngai Lok Lam, Prins Mariska J., Mohammad Nadia Haj, van de Poll-Franse Lonneke V., Zwinderman Aeilko H., van Oijen Martijn G. H., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis: systematic review and meta-analysis Journal of the National Cancer Institute 2020;112 (1):12-29 [PubMed]

2019

  • Kruizinga Renske, Scherer-Rath Michael, Schilderman Johannes B. AM, Hartog Iris D., van der Loos Jacoba P. M., Kotzé Hantie P., Westermann Anneke M., Klümpen Heinz-Josef, Kortekaas Francesco, Grootscholten Cecile, Bossink Frans, Schrama Jolanda, van de Vrande Willem, Schrama Natascha A. WP, Blokland Willem, de Vos Filip Y. FL, Kuin Annemieke, Meijer Wim G., van Oijen Martijn G. H., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. An assisted structured reflection on life events and life goals in advanced cancer patients: Outcomes of a randomized controlled trial (Life InSight Application (LISA) study) Palliative medicine 2019;33 (2):221-231 [PubMed]
  • Dijksterhuis Willemieke P.M., Pruijt Maarten J., van der Woude Stephanie O., Klaassen Remy, Kurk Sophie A., van Oijen Martijn G.H., van Laarhoven Hanneke W.M. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE 2019;10 (1):199-206 [PubMed]
  • van den Ende Tom, Abe Nijenhuis Frank A., van den Boorn H. ctor G., ter Veer Emil, Hulshof Maarten C. C. M., Gisbertz Suzanne S., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis Frontiers in oncology 2019;9 [PubMed]
  • van den Ende Tom, Menting Stef P, Ambarus Carmen A, van Oijen Martijn G H, van Laarhoven Hanneke W M Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye oncologist 2019;24 (4):e149-e153 [PubMed]
  • Kampshoff Caroline S., Verdonck-de Leeuw Irma M., van Oijen Martijn G., Sprangers Mirjam A., Buffart Laurien M. Ecological momentary assessments among patients with cancer: A scoping review European journal of cancer care 2019;28 (3):e13095 [PubMed]
  • Keikes Lotte, de Vos-Geelen Judith, de Groot Jan Willem B., Punt Cornelis J. A., Simkens Lieke H. J., Trajkovic-Vidakovic Marija, Portielje Johanneke E. A., Vos Allert H., Beerepoot Laurens V., Hunting Cornelis B., Koopman Miriam, van Oijen Martijn G. H. Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer Patient education and counseling 2019;102 (7):1331-1335 [PubMed]
  • Schokker Sandor, van der Woude Stephanie O., van Kleef Jessy Joy, van Zoen Daan J., van Oijen Martijn G. H., Mearadji Banafsche, Beenen Ludo F. M., Stroes Charlotte I., Waasdorp Cynthia, Jibodh R. Aarti, Creemers Aafke, Meijer Sybren L., Hooijer Gerrit K. J., Punt Cornelis J. A., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Phase I Dose escalation study with expansion cohort of the addition of nab-paclitaxel to capecitabine and oxaliplatin (CapOx) as first-line treatment of metastatic esophagogastric adenocarcinoma (ACTION study) Cancers 2019;11 (6) [PubMed]
  • van den Ende Tom, Veer Emilter, Mali Rosa M. A., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Prognostic and predictive factors for the curative treatment of esophageal and gastric cancer in randomized controlled trials: A systematic review and meta-analysis Cancers 2019;11 (4) [PubMed]
  • Belkouz Ali, Labeur Tim A., Dierks Joeri, Dijk Frederike, van Oijen Martijn G. H., Verheij Joanne, van Gulik Thomas M., van de Vijver Marc J., Wilmink Hanneke, Punt Cornelis J. A., Klümpen Heinz-Josef Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis Critical reviews in oncology/hematology 2019;141:82-94 [PubMed]
  • van den Boorn Héctor G, Abu-Hanna Ameen, Ter Veer Emil, van Kleef Jessy Joy, Lordick Florian, Stahl Michael, Ajani Jaffer A, Guimbaud Rosine, Park Se Hoon, Dutton Susan J, Bang Yung-Jue, Boku Narikazu, Mohammad Nadia Haj, Sprangers Mirjam A G, Verhoeven Rob H A, Zwinderman Aeilko H, van Oijen Martijn G H, van Laarhoven Hanneke W M SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer Cancers 2019;11 (2):E187 [PubMed]
  • ter Veer Emil Systematic approach to unify evidence for advanced upper gastrointestinal cancer treatment 2019. 555p. ISBN 9789463325622. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Laarhoven H. W. M.; Co-supervisor: van Oijen M. G. H.)
  • van den Ende Tom, ter Veer Emil, Machiels M. lanie, Mali Rosa M. A., Abe Nijenhuis Frank A., de Waal Laura, Laarman Marety, Gisbertz Suzanne S., Hulshof Maarten C. C. M., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The efficacy and safety of (Neo)adjuvant therapy for gastric cancer: A network meta-analysis Cancers 2019;11 (1) [PubMed]
  • ter Veer Emil, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The use of (Network) meta-analysis in clinical oncology Frontiers in oncology 2019;9 (AUG) [PubMed]
  • Ngai Lok Lam, ter Veer Emil, van den Boorn H. ctor G., van Herk E. Hugo, van Kleef Jessy Joy, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. TOXview: a novel graphical presentation of cancer treatment toxicity profiles Acta oncologica (Stockholm, Sweden) 2019;58 (8):1138-1148 [PubMed]

2018

  • Genc C. G., Klümpen H. J., van Oijen M. G. H., van Eijck C. H. J., Nieveen van Dijkum E. J. M. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands World journal of surgery 2018;42 (2):490-497 [PubMed]
  • Labeur Tim A., ten Cate David W. G., Bart Takkenberg R., Azahaf Hicham, van Oijen Martijn G. H., van Delden Otto M., de Man Robert A., van Vugt Jeroen L. A., IJzermans Jan N. M., Eskens Ferry A. L. M., Klümpen Heinz-Josef Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma Acta oncologica (Stockholm, Sweden) 2018;57 (11):1467-1474 [PubMed]
  • Creemers Aafke, Ebbing Eva A., Pelgrim Thomas C., Lagarde Sjoerd M., van Etten-Jamaludin Faridi S., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., Krishnadath Kausilia K., Meijer Sybren L., Bijlsma Maarten F., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas Scientific reports 2018;8 (1) [PubMed]
  • ter Veer Emil, Creemers Aafke, de Waal Laura, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis International journal of cancer. Journal international du cancer 2018;143 (2):438-448 [PubMed]
  • Goey Kaitlyn K. H., Sørbye Halfdan, Glimelius Bengt, Adams Richard A., André Thierry, Arnold Dirk, Berlin Jordan D., Bodoky György, de Gramont Aimery, Díaz-Rubio Eduardo, Eng Cathy, Falcone Alfredo, Grothey Axel, Heinemann Volker, Hochster Howard S., Kaplan Richard S., Kopetz Scott, Labianca Roberto, Lieu Christopher H., Meropol Neal J., Price Timothy J., Schilsky Richard L., Schmoll Hans-Joachim, Shacham-Shmueli Einat, Shi Qian, Sobrero Alberto F., Souglakos John, van Cutsem Eric, Zalcberg John, van Oijen Martijn G. H., Punt Cornelis J. A., Koopman Miriam Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group European journal of cancer (Oxford, England 2018;100:35-45 [PubMed]
  • ter Veer Emil, van Rijssen L. Bengt, Besselink Marc G., Mali Rosa M. A., Berlin Jordan D., Boeck Stefan, Bonnetain Franck, Chau Ian, Conroy Thierry, van Cutsem Eric, Deplanque Gael, Friess Helmut, Glimelius Bengt, Goldstein David, Herrmann Richard, Labianca Roberto, van Laethem Jean-Luc, Macarulla Teresa, van der Meer Jonathan H. M., Neoptolemos John P., Okusaka Takuji, O'Reilly Eileen M., Pelzer Uwe, Philip Philip A., van der Poel Marcel J., Reni Michele, Scheithauer Werner, Siveke Jens T., Verslype Chris, Busch Olivier R., Wilmink Johanna W., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease lancet oncology 2018;19 (3):e151-e160
  • ter Veer Emil, van den Ende Tom, Creemers Aafke, de Waal Laura, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis Acta oncologica (Stockholm, Sweden) 2018;57 (12):1599-1604 [PubMed]
  • van der Have Mike, Oldenburg Bas, Kaptein Ad A., Jansen Jeroen M., Scheffer Robert C. H., van Tuyl Bas A., van der Meulen-de Jong Andrea E., Pierik Marieke, Siersema Peter D., van Oijen Martijn G. H., Fidder Herma H. Corrigendum: Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study Journal of Crohn s & colitis 2018;12 (11):1381 [PubMed]
  • Krol Robin, van Oijen Martijn G. H. Editorial: proton pump inhibitors (PPIs) and microscopic colitis Alimentary pharmacology & therapeutics 2018;48 (8):880-881 [PubMed]
  • Keikes Lotte, van Oijen Martijn G. H., Lemmens Valery E. P. P., Koopman Miriam, Punt Cornelis J. A. Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group Clinical colorectal cancer 2018;17 (1):58-64 [PubMed]
  • Degeling Koen, Franken Mira D., May Anne M., van Oijen Martijn G. H., Koopman Miriam, Punt Cornelis J. A., IJzerman Maarten J., Koffijberg Hendrik Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients Cancer epidemiology 2018;57:60-67 [PubMed]
  • Coebergh van den Braak R. R. J., van Rijssen L. B., van Kleef J. J., Vink G. R., Berbee M., van Berge Henegouwen M. I., Bloemendal H. J., Bruno M. J., Burgmans M. C., Busch O. R. C., Coene P. P. L. O., Coupé V. M. H., Dekker J. W. T., van Eijck C. H. J., Elferink M. A. G., Erdkamp F. L. G., van Grevenstein W. M. U., de Groot J. W. B., van Grieken N. C. T., de Hingh I. H. J. T., Hulshof M. C. C. M., Ijzermans J. N. M., Kwakkenbos L., Lemmens V. E. P. P., Los M., Meijer G. A., Molenaar I. Q., Nieuwenhuijzen G. A. P., de Noo M. E., van de Poll-Franse L. V., Punt C. J. A., Rietbroek R. C., Roeloffzen W. W. H., Rozema T., Ruurda J. P., van Sandick J. W., Schiphorst A. H. W., Schipper H., Siersema P. D., Slingerland M., Sommeijer D. W., Spaander M. C. W., Sprangers M. A. G., Stockmann H. B. A. C., Strijker M., van Tienhoven G., Timmermans L. M., Tjin-A-Ton M. L. R., van der Velden A. M. T., Verhaar M. J., Verkooijen H. M., Vles W. J., de Vos-Geelen J. M. P. G. M., Wilmink J. W., Zimmerman D. D. E., van Oijen M. G. H., Koopman M., Besselink M. G. H., van Laarhoven H. W. M. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative Acta oncologica (Stockholm, Sweden) 2018;57 (2):195-202 [PubMed]
  • Goey Kaitlyn K. H. Predicting treatment outcomes in metastatic colorectal cancer: heterogeneity in patient characteristics, treatment efficacy and molecular diagnosticsUtrecht: Gildeprint Drukkerijen - Enschede; 2018. 193p. ISBN 9789462338760. [UvA Dissertations Online] UMC Utrecht. (Supervisors: Koopman M., Punt C. J. A.; Co-supervisor: van Oijen M. G. H.)
  • van den Boorn H. G., Engelhardt E. G., van Kleef J., Sprangers M. A. G., van Oijen M. G. H., Abu-Hanna A., Zwinderman A. H., Coupé V. M. H., van Laarhoven H. W. M. Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis PLoS ONE 2018;13 (2):e0192310 [PubMed]
  • ter Veer Emil, van Kleef Jessy Joy, Schokker Sandor, van der Woude Stephanie O., Laarman Marety, Haj Mohammad Nadia, Sprangers Mirjam A. G., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis European journal of cancer (Oxford, England 2018;103:214-226 [PubMed]
  • van Kleef J. J., van de Poll-Franse L. V., Verhoeven R. H., Slingerland M., Ruurda J. P., Heisterkamp J., Rosman C., de Groot J. W. B., Kouwenhoven E. A., van Dijk M. A., de Graaf E., van Voorthuizen T., Daams F., Lagarde S., Nieuwenhuijzen G. A. P., Vincent J., van Berge Henegouwen M., van Oijen M. G. H., Sprangers M. A. G., van Laarhoven H. W. M. Prospective observational cohort study of oesophagogastric cancer patients (POCOP): A Dutch nationwide cohort Annals of oncology 2018;29:viii234 [PubMed]
  • ter Veer Emil, van Kleef Jessy Joy, Sprangers Mirjam A. G., Haj Mohammad Nadia, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review Gastric cancer 2018;21 (2):183-195 [PubMed]
  • Goey Kaitlyn K. H., Mahmoud Remi, Sørbye Halfdan, Glimelius Bengt, Köhne Claus-Henning, Sargent Daniel J., Punt Cornelis J. A., van Oijen Martijn G. H., Koopman Miriam Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review European journal of cancer (Oxford, England 2018;96:115-124 [PubMed]
  • Creemers Aafke, Ebbing Eva A., Hooijer Gerrit K. J., Stap Lisanne, Jibodh-Mulder Rajni A., Gisbertz Susanne S., Henegouwen Mark I. van Berge, van Montfoort Maurits L., Hulshof Maarten C. C. M., Krishnadath Kausilia K., van Oijen Martijn G. H., Bijlsma Maarten F., Meijer Sybren L., van Laarhoven Hanneke W. M. The dynamics of HER2 status in esophageal adenocarcinoma Oncotarget 2018;9 (42):26787-26799 [PubMed]
  • van den Ende T., ter Veer E., Machiels M., Mali R. M. A., Abe Nijenhuis F. A., Waal L. D., Laarman M., Gisbertz S. S., Hulshof M. C. C. M., van Oijen M. G. H., van Laarhoven H. W. M. The efficacy and safety of (neo)adjuvant therapy for gastric cancer: A network meta-analysis Annals of oncology 2018;29:viii227 [PubMed]
  • Bos A. C. R. K., Matthijsen R. A., van Erning F. N., van Oijen M. G. H., Rutten H. J. T., Lemmens V. E. P. P. Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study Annals of surgical oncology 2018;25 (2):414-421 [PubMed]

2017

  • ter Veer Emil, Ngai Lok Lam, van Valkenhoef Gert, Haj Mohammad Nadia, Anderegg Maarten C. J., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis Scientific reports 2017;7 (1):7142 [PubMed]
  • Creemers A., Krausz S., Strijker M., van der Wel M. J., Soer E. C., Reinten R. J., Besselink M. G., Wilmink J. W., van de Vijver M. J., van Noesel C. J. M., Verheij J., Meijer S. L., Dijk F., Bijlsma M. F., van Oijen M. G. H., van Laarhoven H. W. M. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS 2017;1868 (2):394-403 [PubMed]
  • Goey Kaitlyn K. H., Elias Sjoerd G., Hinke Axel, van Oijen Martijn G. H., Punt Cornelis J. A., Hegewisch-Becker Susanna, Arnold Dirk, Koopman Miriam Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials British journal of cancer 2017;117 (12):1768-1776 [PubMed]
  • Franken M. D., van Rooijen E. M., May A. M., Koffijberg H., van Tinteren H., Mol L., ten Tije A. J., Creemers G. J., van der Velden A. M. T., Tanis B. C., Uyl-de Groot C. A., Punt C. J. A., Koopman M., van Oijen M. G. H. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer European journal of cancer (Oxford, England 2017;75:204-212 [PubMed]
  • Creemers A., ter Veer E., de Waal L., Lodder P., Hooijer G. K. J., van Grieken N. C. T., Bijlsma M. F., Meijer S. L., van Oijen M. G. H., van Laarhoven H. W. M. Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis Scientific reports 2017;7 (1):3135 [PubMed]
  • Belderbos Tim D. G. Endoscopic detection and treatment of colorectal polyps 2017. 215p. ISBN 9789789077588. [UvA Dissertations Online] Utrecht University: UMCU. (Supervisor: Siersema P. D.; Co-supervisors: ter Linde J. J. M., van Oijen M. G. H.)
  • Keikes Lotte, Koopman Miriam, Tanis Pieter J., Lemmens Valery E. P. P., Punt Cornelis J. A., van Oijen Martijn G. H. Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review European journal of cancer (Oxford, England 2017;86:166-177 [PubMed]
  • Swager Anne-Fré, Tearney Guillermo J., Leggett Cadman L., van Oijen Martijn G. H., Meijer Sybren L., Weusten Bas L., Curvers Wouter L., Bergman Jacques J. G. H. M. Identification of volumetric laser endomicroscopy features predictive for early neoplasia in Barrett's esophagus using high-quality histological correlation Gastrointestinal endoscopy 2017;85 (5):918-926.e7 [PubMed]
  • Belderbos Tim D. G., van Oijen Martijn G. H., Moons Leon M. G., Siersema Peter D. Implementation of real-time probe-based confocal laser endomicroscopy (pCLE) for differentiation of colorectal polyps during routine colonoscopy Endoscopy international open 2017;5 (11):E1104-E1110 [PubMed]
  • Fouché Jacobus Johannes, van Loghem Jani Adriaan Jochem, Thuis Job, de Heer Linda Marije, van Oijen Martijn G. H. Left/Right Pain Asymmetry With Injectable Cosmetic Treatments for the Face Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery 2017;37 (6):708-714 [PubMed]
  • Belderbos Tim D. G., van Erning Felice N., de Hingh Ignace H. J. T., van Oijen Martijn G. H., Lemmens Valery E. P. P., Siersema Peter D. Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based Study Clinical gastroenterology and hepatology 2017;15 (3):403-411.e1 [PubMed]
  • Brand Eelco C., Dik Vincent K., van Oijen Martijn G. H., Siersema Peter D. Missed adenomas with behind-folds visualizing colonoscopy technologies compared with standard colonoscopy: a pooled analysis of 3 randomized back-to-back tandem colonoscopy studies Gastrointestinal endoscopy 2017;86 (2):376-+ [PubMed]
  • Belderbos Tim D. G., Pullens Hendrikus J. M., Leenders Max, Schipper Marguerite E. I., Siersema Peter D., van Oijen Martijn G. H. Risk of post-colonoscopy colorectal cancer due to incomplete adenoma resection: A nationwide, population-based cohort study United European gastroenterology journal 2017;5 (3):440-447 [PubMed]
  • Keikes Lotte, Medlock Stephanie, van de Berg Daniël J,, Zhang Shuxin, Guicherit Onno R., Punt Cornelis J. A., van Oijen Martijn G. H. The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology Journal of clinical and translational research 2017;3 (S3):411-423
  • van Deen Welmoed K., Spiro Arlen, Burak Ozbay A., Skup Martha, Centeno Adriana, Duran Natalie E., Lacey Precious N., Jatulis Darius, Esrailian Eric, van Oijen Martijn G. H., Hommes Daniel W. The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study European journal of gastroenterology & hepatology 2017;29 (3):331-337 [PubMed]
  • Butter R., Lagarde S. M., van Oijen M. G. H., Anderegg M. C. J., Gisbertz S. S., Meijer S. L., Hulshof M. C. C. M., Bergman J. J. G. H. M., van Berge Henegouwen M. I., van Laarhoven H. W. M. Treatment strategies in recurrent esophageal or junctional cancer Diseases of the esophagus 2017;30 (9):1-9 [PubMed]
  • van Deen Welmoed K., Nguyen Dominic, Duran Natalie E., Kane Ellen, van Oijen Martijn G. H., Hommes Daniel W. Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients' preferences Quality of life research 2017;26 (2):455-465 [PubMed]
  • Opstelten Jorrit L., de Wijkerslooth Laetitia R. H., Leenders Max, Bac Dirk Jan, Brink Menno A., Loffeld Boudewijn C. A. J., Meijnen-Bult Mariëlle J. F., Minderhoud Itta M., Verhagen Marc A. M. T., van Oijen Martijn G. H., Siersema Peter D. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions Diseases of the esophagus 2017;30 (2):1-7 [PubMed]
  • Haj Mohammad N., Bernards N., van Putten M., Lemmens V. E. P. P., van Oijen M. G. H., van Laarhoven H. W. M. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer European journal of cancer (Oxford, England 2017;78:28-36 [PubMed]

2016

  • Franken Mira D., Koopman Miriam, van Oijen Martijn G. H. Cetuximab as First-line Treatment for Metastatic Colorectal Cancer: Caution With Interpretation of Cost-Effectiveness Results Toward Medical Decision Making American journal of clinical oncology 2016;39 (2):214 [PubMed]
  • Taleban Sasha, van Oijen Martijn G. H., Vasiliauskas Eric A., Fleshner Phillip R., Shen Bo, Ippoliti Andrew F., Targan Stephan R., Melmed Gil Y. Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis Digestive diseases and sciences 2016;61 (2):550-559 [PubMed]
  • Pullens Hendrikus J. M., van der Stap Nanda, Rozeboom Esther D., Schwartz Matthijs P., van der Heijden Ferdi, van Oijen Martijn G. H., Siersema Peter D., Broeders Ivo A. M. J. Colonoscopy with robotic steering and automated lumen centralization: a feasibility study in a colon model Endoscopy 2016;48 (3):286-290 [PubMed]
  • Haj Mohammad Nadia Daily clinical practice and patterns of care in upper gastrointestinal cancer treatment 2016. 271p. ISBN 9789462334649. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M., Lemmens V. E. P. P.; Co-supervisors: van Oijen M. G. H., Hulshof M. C. C. M.)
  • Schölvinck Dirk W., Goto Osamu, Seldenrijk Cornelis A., Bisschops Raf, Horii Joichiro, Ochiai Yasutoshi, Schoon Erik J., Schenk Boudewijn E., Uraoka Toshio, van Oijen Martijn G. H., Bergman Jacques J. G. H. M., Yahagi Naohisa, Weusten Bas L. A. M. Detection of palisade vessels as a landmark for Barrett's esophagus in a Western population Journal of gastroenterology 2016;51 (7):682-690 [PubMed]
  • van Deen Welmoed K., van der Meulen-de Jong Andrea E., Parekh Nimisha K., Kane Ellen, Zand Aria, DiNicola Courtney A., Hall Laurin, Inserra Elizabeth K., Choi Jennifer M., Ha Christina Y., Esrailian Eric, van Oijen Martijn G. H., Hommes Daniel W. Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies Clinical gastroenterology and hepatology 2016;14 (12):1742-1750.e7 [PubMed]
  • Creemers A., Ebbing E. A., Hooijer G. K. J., Jibodh-Mulder A. R. A., Gisbertz S. S., van Oijen M. G. H., Henegouwen M. Ivan Berge, Bijlsma M. F., Meijer S. L., van Laarhoven H. W. M. Dynamics of the HER2 receptor in esophageal adenocarcinoma: New opportunities for targeted therapy Annals of oncology 2016;27:vi227
  • Dik Vincent K., van Oijen Martijn G. H., Smeets Hugo M., Siersema Peter D. Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study Digestive diseases and sciences 2016;61 (1):255-264 [PubMed]
  • Kuijpers Chantal C. H. J., Sluijter Caro E., von der Thüsen Jan H., Grünberg Katrien, van Oijen Martijn G. H., van Diest Paul J., Jiwa Mehdi, Nagtegaal Iris D., Overbeek Lucy I. H., Willems Stefan M. Interlaboratory variability in the grading of dysplasia in a nationwide cohort of colorectal adenomas Histopathology 2016;69 (2):187-197 [PubMed]
  • Kuijpers Chantal C. H. J., Sluijter Caro E., von der Thüsen Jan H., Grünberg Katrien, van Oijen Martijn G. H., van Diest Paul J., Jiwa Mehdi, Nagtegaal Iris D., Overbeek Lucy I. H., Willems Stefan M. Interlaboratory Variability in the Histologic Grading of Colorectal Adenocarcinomas in a Nationwide Cohort American journal of surgical pathology 2016;40 (8):1100-1108 [PubMed]
  • Dik Vincent K., Hooge Ignace T. C., van Oijen Martijn G. H., Siersema Peter D. Measuring gaze patterns during colonoscopy: a useful tool to evaluate colon inspection? European journal of gastroenterology & hepatology 2016;28 (12):1400-1406 [PubMed]
  • Bos Amanda C. R. K., van Erning Felice N., Elferink Marloes A. G., Rutten Harm J., van Oijen Martijn G. H., de Wilt Johannes H. W., Lemmens Valery E. P. P. No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands Diseases of the colon and rectum 2016;59 (10):943-952 [PubMed]
  • van der Have Mike, Oldenburg Bas, Kaptein Ad A., Jansen Jeroen M., Scheffer Robert C. H., van Tuyl Bas A., van der Meulen-de Jong Andrea E., Pierik Marieke, Siersema Peter D., van Oijen Martijn G. H., Fidder Herma H. Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study Journal of Crohn s & colitis 2016;10 (5):549-555 [PubMed]
  • Burbach J. P. M., Kurk S. A., Coebergh van den Braak R. R. J., Dik V. K., May A. M., Meijer G. A., Punt C. J. A., Vink G. R., Los M., Hoogerbrugge N., Huijgens P. C., Ijzermans J. N. M., Kuipers E. J., de Noo M. E., Pennings J. P., van der Velden A. M. T., Verhoef C., Siersema P. D., van Oijen M. G. H., Verkooijen H. M., Koopman M. Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research Acta oncologica (Stockholm, Sweden) 2016;55 (11):1273-1280 [PubMed]
  • ter Veer Emil, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. S-1 with leucovorin and oxaliplatin for advanced gastric cancer lancet oncology 2016;17 (2):E41 [PubMed]
  • ter Veer Emil, Haj Mohammad Nadia, van Valkenhoef Gert, Ngai Lok Lam, Mali Rosa M. A., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature Cancer metastasis reviews 2016;35 (3):439-456 [PubMed]
  • Goey Kaitlyn K. H., 't Lam-Boer Jorine, de Wilt Johannes H. W., Punt Cornelis J. A., van Oijen Martijn G. H., Koopman Miriam Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review European journal of cancer (Oxford, England 2016;69:166-177 [PubMed]
  • ter Veer Emil, Haj Mohammad Nadia, van Valkenhoef Gert, Ngai Lok Lam, Mali Rosa M. A., Anderegg Maarten C., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis Journal of the National Cancer Institute 2016;108 (10):djw166 [PubMed]
  • ter Veer Emil, Haj Mohammad Nadia, Lodder Paul, Ngai Lok Lam, Samaan Mary, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis Gastric cancer 2016;19 (3):696-712 [PubMed]
  • Belderbos Tim D. G., van Oijen Martijn G. H., Moons Leon M. G., Siersema Peter D. The "golden retriever" study: improving polyp retrieval rates by providing education and competitive feedback Gastrointestinal endoscopy 2016;83 (3):596-601 [PubMed]
  • Huiskens Joost, Bakker J. M., Coelen Robert J. S., Olthof Pim B., Schijven Marie-Elisabeth P., van Oijen Martijn G. H., van Gulik Thomas M. The impact of a mobile application on awareness for multi-center clinical colorectal cancer trials: First results of the Dutch Colorectal Cancer Group (DCCG) HPB: The official journal of the International Hepato Pancreato Biliary Association 2016;18:E291
  • van Deen Welmoed K. Value-Based Health Care in Inflammatory Bowel Diseases 2016. 146p. ISBN 9789462332195. [UvA Dissertations Online] Universiteit Leiden: LUMC. (Supervisor: Hommes D. W.; Co-supervisors: van Oijen M. G. H., Veenendaal R. A.)

2015

  • Trumpi K., Emmink B. L., Prins A. M., van Oijen M. G. H., van Diest P. J., Punt C. J. A., Koopman M., Kranenburg O., Borel Rinkes I. H. M. ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer Journal of Cancer 2015;6 (11):1079-1086 [PubMed]
  • Lutgens Maurice, Vermeire Séverine, van Oijen Martijn, Vleggaar Frank, Siersema Peter, van Assche Gert, Rutgeerts Paul, Oldenburg Bas A Rule for Determining Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Clinical gastroenterology and hepatology 2015;13 (1):148-U221 [PubMed]
  • Haj Mohammad N., Walter A. W., van Oijen M. G. H., Hulshof M. C. C. M., Bergman J. J. G. H. M., Anderegg M. C. J., van Berge Henegouwen M. I., Henselmans I., Sprangers M. A. G., van Laarhoven H. W. M. Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent Supportive care in cancer 2015;23 (12):3589-3598 [PubMed]
  • Belderbos Tim D. G., Grobbee Elisabeth J., van Oijen Martijn G. H., Meijssen Maarten A. C., Ouwendijk Rob J. T., Tang Thjon J., ter Borg Frank, van der Schaar Peter, Le Fèvre Doris M., Stouten Merijn T., van der Galiën Onno, Hiemstra Theo J., de Vos tot Nederveen Cappel Wouter H., ter Borg Pieter C. J., Spaander Manon C. W., Moons Leon M. G., Kuipers Ernst J., Siersema Peter D. Comparison of cecal intubation and adenoma detection between hospitals can provide incentives to improve quality of colonoscopy Endoscopy 2015;47 (8):703-709 [PubMed]
  • Bromley Erica G., May Folasade P., Federer Lisa, Spiegel Brennan M. R., van Oijen Martijn G. H. Explaining persistent under-use of colonoscopic cancer screening in African Americans: A systematic review Preventive medicine 2015;71:40-48 [PubMed]
  • Spierings L. E. A. M. M., Lagarde S. M., van Oijen M. G. H., Gisbertz S. S., Wilmink J. W., Hulshof M. C. C. M., Meijer S. L., Anderegg M. C., van Berge Henegouwen M. I., van Laarhoven H. W. M. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes Annals of surgical oncology 2015;22 (Suppl. 3):S766-S771 [PubMed]
  • Pullens Hendrikus J. M., Leenders Max, Schipper Marguerite E. I., van Oijen Martijn G. H., Siersema Peter D. No Decrease in the Rate of Early or Missed Colorectal Cancers After Colonoscopy With Polypectomy Over a 10-Year Period: A Population-Based Analysis Clinical gastroenterology and hepatology 2015;13 (1):140-147 [PubMed]
  • van Meer Suzanne, de Man Robert A., van den Berg Aad P., Houwen Roderick H. J., Linn Francisca H. H., van Oijen Martijn G. H., Siersema Peter D., van Erpecum Karel J. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up Journal of gastroenterology and hepatology 2015;30 (3):535-539 [PubMed]
  • Haj Mohammad N., ter Veer E., Ngai L., Mali R., van Oijen M. G. H., van Laarhoven H. W. M. Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Cancer metastasis reviews 2015;34 (3):429-441 [PubMed]
  • Pullens Hendrikus J. M. Optimizing colonoscopy outcomes in daily clinical practice 2015. 181p. ISBN 9789461696540. [UvA Dissertations Online] University of Utrecht: Faculty of Medicine. (Supervisor: Siersema P. D.; Co-supervisor: van Oijen M. G. H.)
  • Dik Vincent K., Moons Leon M. G., Hüyük Melek, van der Schaar Peter, de Vos tot Nederveen Cappel Wouter H., ter Borg Pieter C. J., Meijssen Maarten A. C., Ouwendijk Rob J. T. H., Le Fèvre Doris M., Stouten Merijn, van der Galiën Onno, Hiemstra Theo J., Monkelbaan Jan F., van Oijen Martijn G. H., Siersema Peter D., Tang Thjon J., ter Borg Frank, Kuipers Ernst J. Predicting inadequate bowel preparation for colonoscopy in participants receiving split-dose bowel preparation: development and validation of a prediction score Gastrointestinal endoscopy 2015;81 (3):665-672 [PubMed]
  • Dik Vincent K. Prevention of colorectal cancer development and mortality: from epidemiology to endoscopy 2015. 253p. ISBN 9789461696571. [UvA Dissertations Online] University of Utrecht: Faculty of Medicine. (Supervisor: Siersema P. D.; Co-supervisors: van Oijen M. G. H., Bueno-de-Mesquita H. B.)
  • van Meer Suzanne, de Man Robert A., Coenraad Minneke J., Sprengers Dave, van Nieuwkerk Karin M. J., Klümpen Heinz-Josef, Jansen Peter L. M., Ijzermans Jan N. M., van Oijen Martijn G. H., Siersema Peter D., van Erpecum Karel J. Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands Journal of hepatology 2015;63 (5):1156-1163 [PubMed]
  • Bos A. C. R. K., van Erning F. N., van Gestel Y. R. B. M., Creemers G. J. M., Punt C. J. A., van Oijen M. G. H., Lemmens V. E. P. P. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer European journal of cancer (Oxford, England 2015;51 (17):2553-2561 [PubMed]

2014

  • van Deen Welmoed K., van Oijen Martijn G. H., Myers Kelly D., Centeno Adriana, Howard William, Choi Jennifer M., Roth Bennett E., McLaughlin Erin M., Hollander Daniel, Wong-Swanson Belinda, Sack Jonathan, Ong Michael K., Ha Christina Y., Esrailian Eric, Hommes Daniel W. A Nationwide 2010-2012 Analysis of U.S. Health Care Utilization in Inflammatory Bowel Diseases Inflammatory bowel diseases 2014;20 (10):1747-1753 [PubMed]
  • Schurink Bernadette, Tielemans Merel M., Aaldering Bryan R. R. Z., Eikendal Ties, Focks Jeroen Jaspers, Laheij Robert J. F., Jansen Jan B. M. J., van Rossum Leo G. M., van Oijen Martijn G. H. Antidepressants and Gastrointestinal Symptoms in the General Dutch Adult Population Journal of clinical psychopharmacology 2014;34 (1):66-71 [PubMed]
  • Lutgens Maurice, van Oijen Martijn, Mooiweer Erik, van der Valk Mirthe, Vleggaar Frank, Siersema Peter, Oldenburg Bas A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines Gastrointestinal endoscopy 2014;80 (5):842-848 [PubMed]
  • Dik V. K., Aarts M. J., van Grevenstein W. M. U., Koopman M., van Oijen M. G. H., Lemmens V. E., Siersema P. D. Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer British journal of surgery 2014;101 (9):1173-1182 [PubMed]
  • van den Bemt Patricia M. L. A., Tjwa Eric T. T. L., van Oijen Martijn G. H. Cardiovasculaire en gastro-intestinale veiligheid van NSAID's Nederlands tijdschrift voor geneeskunde 2014;158:A7311 [PubMed]
  • Dik Vincent K., Bueno-de-Mesquita H. B. As, van Oijen Martijn G. H., Siersema Peter D., Uiterwaal Cuno S. P. M., van Gils Carla H., van Duijnhoven Fränzel J. B., Cauchi Stéphane, Yengo Loic, Froguel Philippe, Overvad Kim, Bech Bodil H., Tjønneland Anne, Olsen Anja, Boutron-Ruault Marie-Christine, Racine Antoine, Fagherazzi Guy, Kühn Tilman, Campa Daniele, Boeing Heiner, Aleksandrova Krasimira, Trichopoulou Antonia, Peppa Eleni, Oikonomou Eleni, Palli Domenico, Grioni Sara, Vineis Paolo, Tumino Rosaria, Panico Salvatore, Peeters Petra H. M., Weiderpass Elisabete, Engeset Dagrun, Braaten Tonje, Dorronsoro Miren, Chirlaque María-Dolores, Sánchez María-José, Barricarte Aurelio, Zamora-Ros Raul, Argüelles Marcial, Jirström Karin, Wallström Peter, Nilsson Lena M., Ljuslinder Ingrid, Travis Ruth C., Khaw Kay-Tee, Wareham Nick, Freisling Heinz, Licaj Idlir, Jenab Mazda, Gunter Marc J., Murphy Neil, Romaguera-Bosch Dora, Riboli Elio Coffee and tea consumption, genotype- based CYP1A2 and NAT2 activity and colorectal cancer risk- Results from the EPIC cohort study International journal of cancer. Journal international du cancer 2014;135 (2):401-412 [PubMed]
  • Verbeek Romy E., van Oijen Martijn G. H., ten Kate Fiebo J., Vleggaar Frank P., van Baal Jantine W. P. M., Siersema Peter D. Consistency of a high-grade dysplasia diagnosis in Barrett's oesophagus: A Dutch nationwide cohort study Digestive and liver disease 2014;46 (4):318-322 [PubMed]
  • Dik Vincent K., Siersema Peter D., Joseph Alain, Hodgkins Paul, Smeets Hugo M., van Oijen Martijn G. H. Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation European journal of gastroenterology & hepatology 2014;26 (11):1260-1266 [PubMed]
  • Verbeek Romy E., Spittuler Lisanne F., Peute Anique, van Oijen Martijn G. H., ten Kate Fiebo J., Vermeijden Jacob R., Oberndorff Ardi, van Baal Jantine W. P. M., Siersema Peter D. Familial Clustering of Barrett's Esophagus and Esophageal Adenocarcinoma in a European Cohort Clinical gastroenterology and hepatology 2014;12 (10):1656-U119 [PubMed]
  • Jaspers Focks J., Tielemans M. M., van Rossum L. G. M., Eikendal T., Brouwer M. A., Jansen J. B. M. J., Laheij R. J. F., Verheugt F. W. A., van Oijen M. G. H. Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin Netherlands heart journal 2014;22 (3):107-112 [PubMed]
  • Tielemans M. M., van Rossum L. G. M., Eikendal T., Focks J. J., Laheij R. J. F., Jansen J. B. M. J., van Oijen M. G. H. Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants International journal of clinical practice 2014;68 (4):512-519 [PubMed]
  • van der Valk Mirthe Emilie, Mangen Marie-Josée J., Leenders Max, Dijkstra Gerard, van Bodegraven Ad A., Fidder Herma H., de Jong Dirk J., Pierik Marieke, van der Woude C. Janneke, Romberg-Camps Mariëlle J. L., Clemens Cees Hm, Jansen Jeroen M., Mahmmod Nofel, van de Meeberg Paul C., van der Meulen-de Jong Andrea E., Ponsioen Cyriel Y., Bolwerk Clemens J. M., Vermeijden J. Reinoud, Siersema Peter D., van Oijen Martijn G. H., Oldenburg Bas Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study Gut 2014;63 (1):72-79 [PubMed]
  • May Folasade P., Bromley Erica G., Reid Mark W., Baek Michael, Yoon Jessica, Cohen Erica, Lee Aaron, van Oijen Martijn G. H., Spiegel Brennan M. R. Low uptake of colorectal cancer screening among African Americans in an integrated Veterans Affairs health care network Gastrointestinal endoscopy 2014;80 (2):291-298 [PubMed]
  • Verbeek Romy Elisabeth Malignant progression of Barrett’s esophagus: pathogenesis, surveillance and follow-up 2014. 209p. ISBN 9789461695581. [UvA Dissertations Online] University Utrecht: -. (Supervisor: Siersema P. D.; Co-supervisors: van Baal J. W. P. M., van Oijen M. G. H.)
  • van der Have Mike, Oldenburg Bas, Fidder Herma H., Belderbos Tim D. G., Siersema Peter D., van Oijen Martijn G. H. Optimizing Screening for Tuberculosis and Hepatitis B Prior to Starting Tumor Necrosis Factor-alpha Inhibitors in Crohn's Disease Digestive diseases and sciences 2014;59 (3):554-563 [PubMed]
  • de Groot N. L., van Oijen M. G. H., Kessels K., Hemmink M., Weusten B. L. A. M., Timmer R., Hazen W. L., van Lelyveld N., Vermeijden J. R., Curvers W. L., Baak L. C., Verburg R., Bosman J. H., de Wijkerslooth L. R. H., de Rooij J., Venneman N. G., Pennings M., van Hee K., Scheffer R. C. H., van Eijk R. L., Meiland R., Siersema P. D., Bredenoord A. J. Prediction scores or gastroenterologists' Gut Feeling for triaging patients that present with acute upper gastrointestinal bleeding United European gastroenterology journal 2014;2 (3):197-205 [PubMed]
  • de Groot Nicolette L., Hagenaars Matthijs P., Smeets Hugo M., Steyerberg Ewout W., Siersema Peter D., van Oijen Martijn G. H. Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts Journal of gastroenterology 2014;49 (2):245-253 [PubMed]
  • Bus Pauline, Lemmens Valery E., van Oijen Martijn G., Creemers Geert-Jan, Nieuwenhuijzen Grard A., van Baal Jantine W., Siersema Peter D. Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands Journal of surgical oncology 2014;109 (5):465-471 [PubMed]
  • de Groot Nicolette L., van Oijen Martijn G. H., Kessels Koen, Hemmink Maarten, Weusten Bas L. A. M., Timmer Robin, Hazen Wouter L., van Lelyveld Niels, Vermeijden Reinoud R., Curvers Wouter L., Baak Bert C., Verburg Robert, Bosman Joukje H., de Wijkerslooth Laetitia R. H., de Rooij Janne, Venneman Niels G., Pennings Marieke, van Hee Koen, Scheffer Bob C. H., van Eijk Rachel L., Meiland Ruby, Siersema Peter D., Bredenoord Albert J. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: can classification be simplified? Endoscopy 2014;46 (1):46-52 [PubMed]
  • van der Valk Mirthe E., Mangen Marie-Josée J., Leenders Max, Dijkstra Gerard, van Bodegraven Ad A., Fidder Herma H., de Jong Dirk J., Pierik Marieke, van der Woude C. Janneke, Romberg-Camps Mariëlle J. L., Clemens Cees H. M., Jansen Jeroen M., Mahmmod Nofel, van de Meeberg Paul C., van der Meulen-de Jong Andrea E., Ponsioen Cyriel Y., Bolwerk Clemens J. M., Vermeijden J. Reinoud, Siersema Peter D., van Oijen Martijn G. H., Oldenburg Bas Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease Journal of Crohn s & colitis 2014;8 (7):590-597 [PubMed]
  • van der Have Mike, Belderbos Tim D. G., Fidder Herma H., Leenders Max, Dijkstra Gerard, Peters Charlotte P., Eshuis Emma J., Ponsioen Cyriel Y., Siersema Peter D., van Oijen Martijn G. H., Oldenburg Bas Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study Digestive and liver disease 2014;46 (10):881-886 [PubMed]
  • Verbeek Romy E., Leenders Max, ten Kate Fiebo J. W., van Hillegersberg Richard, Vleggaar Frank P., van Baal Jantine W. P. M., van Oijen Martijn G. H., Siersema Peter D. Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study American journal of gastroenterology 2014;109 (8):1215-1222 [PubMed]

2013

  • Kestens Christine, van Oijen Martijn G. H., Mulder Charlotte L. J., van Bodegraven Ad A., Dijkstra Gerard, de Jong Dirk, Ponsioen Cyriel, van Tuyl Bas A. C., Siersema Peter D., Fidder Herma H., Oldenburg Bas Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti-Tumor Necrosis Factor-alpha Agents Clinical gastroenterology and hepatology 2013;11 (7):826-831 [PubMed]
  • Wang Hank S., Pisegna Joseph, Modi Rusha, Liang Li-Jung, Atia Mary, Nguyen Minh, Cohen Hartley, Ohning Gordon, van Oijen Martijn, Spiegel Brennan M. R. Adenoma detection rate is necessary but insufficient for distinguishing high versus low endoscopist performance Gastrointestinal endoscopy 2013;77 (1):71-78 [PubMed]
  • van Schaik Fiona D. M., Mooiweer Erik, van der Have Mike, Belderbos Tim D. G., ten Kate Fiebo J. W., Offerhaus G. Johan A., Schipper Marguerite E. I., Dijkstra Gerard, Pierik Marieke, Stokkers Pieter C. F., Ponsioen Cyriel, de Jong Dirk J., Hommes Daniel W., van Bodegraven Ad A., Siersema Peter D., van Oijen Martijn G. H., Oldenburg Bas Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia Inflammatory bowel diseases 2013;19 (2):342-349 [PubMed]
  • Focks Jeroen Jaspers, van Schaik Annie, Clappers Nick, van Dijk Eveline G. J. A., van Oijen Martijn G. H., Verheugt Freek W. A., Peters Wilbert H. M. Assessment of plasma aminothiol levels and the association with recurrent atherothrombotic events in patients hospitalized for an acute coronary syndrome: a prospective study Clinical chemistry and laboratory medicine 2013;51 (11):2187-2193 [PubMed]
  • Whitman Cynthia B., Shreay Sanatan, Gitlin Matthew, van Oijen Martijn G. H., Spiegel Brennan M. R. Clinical Factors and the Decision to Transfuse Chronic Dialysis Patients Clinical journal of the American Society of Nephrology 2013;8 (11):1942-1951 [PubMed]
  • Focks Jeroen Jaspers, Brouwer Marc A., van Oijen Martijn G. H., Lanas Angel, Bhatt Deepak L., Verheugt Freek W. A. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review Heart (British Cardiac Society) 2013;99 (8):520-527 [PubMed]
  • Lutgens Maurice W. M. D., van Oijen Martijn G. H., van der Heijden Geert J. M. G., Vleggaar Frank P., Siersema Peter D., Oldenburg Bas Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies Inflammatory bowel diseases 2013;19 (4):789-799 [PubMed]
  • Künzli Hannah T., Timmer Robin, Schwartz Matthijs P., Witteman Ben J., Weusten Bas L. A. M., van Oijen Martijn G. H., Siersema Peter D., Vleggaar Frank P. Endoscopic ultrasonography-guided drainage is an effective and relatively safe treatment for peripancreatic fluid collections in a cohort of 108 symptomatic patients European journal of gastroenterology & hepatology 2013;25 (8):958-963 [PubMed]
  • Tielemans Merel M., Jaspers Focks Jeroen, van Rossum Leo G. M., Eikendal Ties, Jansen Jan B. M. J., Laheij Robert J. F., van Oijen Martijn G. H. Gastrointestinal Symptoms are Still Prevalent and Negatively Impact Health-Related Quality of Life: A Large Cross-Sectional Population Based Study in The Netherlands PLoS ONE 2013;8 (7):e69876 [PubMed]
  • de Groot N. L., van Haalen H. G. M., Spiegel B. M. R., Laine L., Lanas A., Focks J. Jaspers, Siersema P. D., van Oijen M. G. H. Gastroprotection in Low-Dose Aspirin Users for Primary and Secondary Prevention of ACS: Results of a Cost-Effectiveness Analysis Including Compliance Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2013;27 (4):341-357 [PubMed]
  • de Groot N. L., Spiegel B. M. R., van Haalen H. G. M., de Wit N. J., Siersema P. D., van Oijen M. G. H. Gastroprotective Strategies in Chronic NSAID Users: A Cost-Effectiveness Analysis Comparing Single-Tablet Formulations with Individual Components Value in health 2013;16 (5):769-777 [PubMed]
  • Shahedi Kamyar, Fuller Garth, Bolus Roger, Cohen Erica, Vu Michelle, Shah Rena, Agarwal Nikhil, Kaneshiro Marc, Atia Mary, Sheen Victoria, Kurzbard Nicole, van Oijen Martijn G. H., Yen Linnette, Hodgkins Paul, Erder M. Haim, Spiegel Brennan Long-term Risk of Acute Diverticulitis Among Patients With Incidental Diverticulosis Found During Colonoscopy Clinical gastroenterology and hepatology 2013;11 (12):1609-1613 [PubMed]
  • Fidder Herma H., Singendonk Maartje M. J., van der Have Mike, Oldenburg Bas, van Oijen Martijn G. H. Low rates of adherence for tumor necrosis factor-alpha inhibitors in Crohn's disease and rheumatoid arthritis: Results of a systematic review World journal of gastroenterology 2013;19 (27):4344-4350 [PubMed]
  • Mooiweer Erik, van der Meulen Andrea E., van Bodegraven Adriaan A., Jansen Jeroen M., Mahmmod Nofel, Nijsten Joyce, van Oijen Martijn G. H., Siersema Peter D., Oldenburg Bas Neoplasia Yield and Colonoscopic Workload of Surveillance Regimes for Colorectal Cancer in Colitis Patients: A Retrospective Study Comparing the Performance of the Updated AGA and BSG Guidelines Inflammatory bowel diseases 2013;19 (12):2603-2610 [PubMed]
  • Tielemans Merel M., van Oijen Martijn G. H. Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study BMC gastroenterology 2013;13:UNSP 144 [PubMed]
  • Tielemans Merel Marijn Prevalence and determinants of gastrointestinal symptoms in the Dutch community 2013. 177p. ISBN 9789090277721. [UvA Dissertations Online] Radboud University Nijmegen: Maag-, Darm-, en Leverziekten in het UMC St Radboud. (Supervisor: Drenth J. P. H.; Co-supervisor: van Oijen M. G. H.)
  • de Groot Nicolette L. Risk stratification in upper gastrointestinal bleeding 2013. 209p. ISBN 9789461085016. [UvA Dissertations Online] Universiteit Utrecht: DIGD. (Supervisor: Siersema P. D.; Co-supervisors: van Oijen M. G. H., Bredenoord A. J.)
  • van Meer Suzanne, Leufkens Anke M., Bueno-de-Mesquita H. Bas, van Duijnhoven Fränzel J. B., van Oijen Martijn G. H., Siersema Peter D. Role of dietary factors in survival and mortality in colorectal cancer: a systematic review Nutrition reviews 2013;71 (9):631-641 [PubMed]
  • van Schaik Fiona D. M., Oldenburg Bas, Hart Andrew R., Siersema Peter D., Lindgren Stefan, Grip Olof, Teucher Birgit, Kaaks Rudolf, Bergmann Manuela M., Boeing Heiner, Carbonnel Franck, Jantchou Prevost, Boutron-Ruault Marie-Christine, Tjønneland Anne, Olsen Anja, Crowe Francesca L., Peeters Petra H. M., van Oijen Martijn G. H., Bueno-de-Mesquita H. Bas Serological markers predict inflammatory bowel disease years before the diagnosis Gut 2013;62 (5):683-688 [PubMed]
  • de Jong Hilda J. I., Korevaar Joke C., van Dijk Liset, Voogd Eef, van Dijk Christel E., van Oijen Martijn G. H. Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care BMJ open 2013;3 (7):e003044 [PubMed]
  • Pullens Hendrikus J. M., Laheij Robert J. F., Vleggaar Frank P., van Oijen Martijn G. H., Siersema Peter D. Symptoms associated with finding colorectal cancer during colonoscopy European journal of gastroenterology & hepatology 2013;25 (11):1295-1299 [PubMed]

2012

  • de Groot N. L., Bosman J. H., Siersema P. D., van Oijen M. G. H., Bredenoord A. J. Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study Alimentary pharmacology & therapeutics 2012;36 (5):477-484 [PubMed]
  • van Vugt van Pinxteren Maria W. J., van Kouwen Mariëtte C. A., van Oijen Martijn G. H., van Achterberg Theo, Nagengast Fokko M. A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial Familial cancer 2012;11 (3):337-341 [PubMed]
  • Homs Marjolein Y. V., van Oijen Martijn G. H., Wijnhoven Bas P. L., van Hillegersberg Richard, de Boer-Dennert Maureen, Siersema Peter D. Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009: a survey in the Netherlands European journal of gastroenterology & hepatology 2012;24 (2):126-133 [PubMed]
  • Hirdes Meike M. C., van Hooft Jeanin E., Wijrdeman Harm K., Hulshof Maarten C. C. M., Fockens Paul, Reerink Onne, van Oijen Martijn G. H., van der Tweel Ingeborg, Vleggaar Frank P., Siersema Peter D. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer Gastrointestinal endoscopy 2012;76 (2):267-274 [PubMed]
  • van der Valk Mirthe E., van Oijen Martijn G. H., Ammerlaan Marije, Siersema Peter D., Oldenburg Bas Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators Gut 2012;61 (2):324-325 [PubMed]
  • Mooiweer Erik, Baars Judith E., Lutgens Maurice W. M. D., Vleggaar Frank, van Oijen Martijn, Siersema Peter D., Kuipers Ernst J., van der Woude C. Janneke, Oldenburg Bas Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series Journal of Crohn s & colitis 2012;6 (4):435-440 [PubMed]
  • Hirdes Meike M. C., Monkelbaan Jan F., Haringman Jasper J., van Oijen Martijn G. H., Siersema Peter D., Pullens Hendrikus J. M., Kesecioglu Jozef, Vleggaar Frank P. Endoscopic Clip-Assisted Feeding Tube Placement Reduces Repeat Endoscopy Rate: Results from a Randomized Controlled Trial American journal of gastroenterology 2012;107 (8):1220-1227 [PubMed]
  • Tielemans Merel M., van Oijen Martijn G. H., Mulder Chris J. J., Vos Kees J., Lems Willem F. Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study European journal of gastroenterology & hepatology 2012;24 (3):281-287 [PubMed]
  • Leufkens A. M., van Oijen M. G. H., Vleggaar F. P., Siersema P. D. Factors influencing the miss rate of polyps in a back-to-back colonoscopy study Endoscopy 2012;44 (5):470-475 [PubMed]
  • Duell Eric J., Sala Núria, Travier Noémie, Muñoz Xavier, Boutron-Ruault Marie Christine, Clavel-Chapelon Françoise, Barricarte Aurelio, Arriola Larraitz, Navarro Carmen, Sánchez-Cantalejo Emilio, Quirós J. Ramón, Krogh Vittorio, Vineis Paolo, Mattiello Amalia, Tumino Rosario, Khaw Kay-Tee, Wareham Nicholas, Allen Naomi E., Peeters Petra H., Numans Mattijs E., Bueno-de-Mesquita H. B., van Oijen M. G. H., Bamia Christina, Benetou Vassiliki, Trichopoulos Dimitrios, Canzian Federico, Kaaks Rudolf, Boeing Heiner, Bergmann Manuela M., Lund Eiliv, Ehrnström Roy, Johansen Dorthe, Hallmans Göran, Stenling Roger, Tjønneland Anne, Overvad Kim, Ostergaard Jane Nautrup, Ferrari Pietro, Fedirko Veronika, Jenab Mazda, Nesi Gabriella, Riboli Elio, González Carlos A. Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort Carcinogenesis 2012;33 (2):361-367 [PubMed]
  • Römkens Tessa E. H., Kampschreur Milou T., Drenth Joost P. H., van Oijen Martijn G. H., de Jong Dirk J. High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials Inflammatory bowel diseases 2012;18 (11):2190-2198 [PubMed]
  • van Lelyveld Niels, van Oijen Martijn G. H., Schwartz Matthijs P. Kwaliteitsindicatoren voor coloscopie: verschillen in poliepdetectie tussen endoscopisten in 1 ziekenhuis Nederlands tijdschrift voor geneeskunde 2012;156 (24):A4219 [PubMed]
  • van Zoonen M., van Oijen M. G. H., van Leeuwen M. S., van Hillegersberg R., Siersema P. D., Vleggaar F. P. Low impact of staging EUS for determining surgical resectability in esophageal cancer Surgical endoscopy 2012;26 (10):2828-2834 [PubMed]
  • Tielemans Merel M., Jansen Jan Bmj, van Oijen Martijn Gh Open access capture of patients with gastroesophageal reflux disease using an online patient-reported outcomes instrument Interactive journal of medical research 2012;1 (2):e7 [PubMed]
  • de Groot N. L., Bosman J. H., Siersema P. D., van Oijen M. G. H. Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal Endoscopy 2012;44 (8):731-739 [PubMed]
  • de Jager C. P. C., Wever P. C., Gemen E. F. A., van Oijen M. G. H., van Gageldonk-Lafeber A. B., Siersema P. D., Kusters G. C. M., Laheij R. J. F. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia Alimentary pharmacology & therapeutics 2012;36 (10):941-949 [PubMed]
  • Agréus Lars, Kuipers Ernst J., Kupcinskas Limas, Malfertheiner Peter, Di Mario Francesco, Leja Marcis, Mahachai Varocha, Yaron Niv, van Oijen Martijn, Perez Perez Guillermo, Rugge Massimo, Ronkainen Jukka, Salaspuro Mikko, Sipponen Pentti, Sugano Kentaro, Sung Joseph Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers Scandinavian journal of gastroenterology 2012;47 (2):136-147 [PubMed]
  • Lutgens Maurice W. M. D., van Oijen Martijn G. H., Vleggaar Frank P., Siersema Peter D., Broekman Mark M. T. J., Oldenburg Bas, van Bodegraven Adriaan A., Dijkstra Gerard, Hommes Daniel, de Jong Dirk J., Stokkers Pieter, van der Woude Christien J. Risk Factors for Rectal Stump Cancer in Inflammatory Bowel Disease Diseases of the colon and rectum 2012;55 (2):191-196 [PubMed]
  • van Schaik Fiona D. M., Oldenburg Bas, Offerhaus G. Johan A., Schipper Marguerite E. I., Vleggaar Frank P., Siersema Peter D., van Oijen Martijn G. H., ten Kate Fiebo J. W. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis Inflammatory bowel diseases 2012;18 (3):480-488 [PubMed]
  • Verbeek Romy E., van Oijen Martijn G. H., ten Kate Fiebo J. W., Vleggaar Frank P., Schipper Marguerite E. I., Casparie Mariel K., van Baal Jantine W. P. M., Siersema Peter D. Surveillance and Follow-Up Strategies in Patients With High-Grade Dysplasia in Barrett's Esophagus: A Dutch Population-Based Study American journal of gastroenterology 2012;107 (4):534-542 [PubMed]
  • Bus Pauline, Aarts Mieke J., Lemmens Valery E. P. P., van Oijen Martijn G., Creemers Geert-Jan, Nieuwenhuijzen Grard A., van Baal Jantine W., Siersema Peter D. The Effect of Socioeconomic Status on Staging and Treatment Decisions in Esophageal Cancer Journal of clinical gastroenterology 2012;46 (10):833-839 [PubMed]
  • Chrispijn M., Nevens F., Gevers T. J. G., Vanslembrouck R., van Oijen M. G. H., Coudyzer W., Hoffmann A. L., Dekker H. M., de Man R. A., van Keimpema L., Drenth J. P. H. The long-term outcome of patients with polycystic liver disease treated with lanreotide Alimentary pharmacology & therapeutics 2012;35 (2):266-274 [PubMed]
  • van Schaik Fiona D. M., van Oijen Martijn G. H., Smeets Hugo M., van der Heijden Geert J. M. G., Siersema Peter D., Oldenburg Bas Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease Gut 2012;61 (2):235-240 [PubMed]

2011

  • Dekker N., van Rossum L. G. M., van Vugt-van Pinxteren M., van Stiphout S. H. C., Hermens R. P. M. G., van Zelst-Stams W. A. G., van Oijen M. G. H., Laheij R. J. F., Jansen J. B. M. J., Hoogerbrugge N. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening European journal of cancer (Oxford, England 2011;47 (10):1571-1577 [PubMed]
  • de Vries Hilbert S., van Oijen Martijn G. H., Driessen Rieke J. B., de Jong Elke M. G. J., Creemers Marjonne C. W., Kievit Wietske, de Jong Dirk J. Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists British journal of clinical pharmacology 2011;71 (1):7-19 [PubMed]
  • van Esch A. A. J., de Vries E., te Morsche R. H. M., van Oijen M. G. H., Jansen J. B. M. J., Drenth J. P. H. Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis Netherlands journal of medicine 2011;69 (7-8):330-334 [PubMed]
  • van Rossum Leo G. M., van Rijn Anne F., Verbeek Andre L. M., van Oijen Martijn G. H., Laheij Robert J. F., Fockens Paul, Jansen Jan B. M. J., Adang Eddy M. M., Dekker Evelien Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis International journal of cancer. Journal international du cancer 2011;128 (8):1908-1917 [PubMed]
  • van Marrewijk Corine Jacqueline Diamond: initial management of dyspepsia in primary care: effectiveness, efficiency, and quality of life 2011. 198p. ISBN 9789461081261. [UvA Dissertations Online] Radboud University Nijmegen. (Supervisor: Jansen J. B. M. J.; Co-supervisors: Laheij R. J. F., van Oijen M. G. H.)
  • van Rossum Leo G. M., van Oijen Martijn G. H. Different seasons with decreased performance of immunochemical faecal occult blood tests in colorectal cancer screening Gut 2011;60 (9):1303-1304 [PubMed]
  • Friederich Pieter, Verschuur Jelle, van Heumen Bjorn W. H., Roelofs Hennie M. J., Berkhout Marloes, Nagtegaal Iris D., van Oijen Martijn G. H., van Krieken Johannes H. J. M., Peters Wilbert H. M., Nagengast Fokko M. Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis International journal of colorectal disease 2011;26 (5):575-582 [PubMed]
  • van Oijen Martijn G. H., Siersema Peter D. Effects of Proton Pump Inhibitors in Patients Receiving Clopidogrel Meta-Analysis versus Clinical Practice Drug safety 2011;34 (2):173 [PubMed]
  • Slavenburg Serena Hepatitis C and Ribavirin. Focus on Ribavirin as an important component in hepatitis C treatment 2011. [UvA Dissertations Online] Radboud University Nijmegen. (Supervisor: Drenth J. P.; Co-supervisor: van Oijen M. G. H.)
  • Römkens Tessa E. H., van Vugt-van Pinxteren Maria W. J., Nagengast Fokko M., van Oijen Martijn G. H., de Jong Dirk J. High prevalence of fatigue in inflammatory bowel disease: A case control study Journal of Crohn s & colitis 2011;5 (4):332-337 [PubMed]
  • Horjus C. S., van Oijen M. G. H., Davids A. H., Naber A. H. J., de Jong D. J. Microalbuminuria Is Not a Valuable Marker for Relapse in Crohn's Disease Digestion 2011;83 (1-2):41-45 [PubMed]
  • van Keimpema Loes, de Koning Daan B., van Hoek Bart, van den Berg Aad P., van Oijen Martijn G. H., de Man Robert A., Nevens Frederik, Drenth Joost P. H. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases Liver international 2011;31 (1):92-98 [PubMed]
  • van Vlerken Lotte G., van Oijen Martijn G. H., van Erpecum Karel J. Ribavirin Concentration Is a More Important Predictor of Sustained Viral Response Than Anemia in Hepatitis C Patients Gastroenterology 2011;140 (5):1693-1694 [PubMed]
  • van Schaik Fiona D. M., van Oijen Martijn G. H., Smeets Hugo M., van der Heijden Geert J. M. G., Siersema Peter D., Oldenburg Bas Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Clinical gastroenterology and hepatology 2011;9 (5):449-450 [PubMed]
  • Gevers T. J. G., Slavenburg S., van Oijen M. G. H., Drenth J. P. H. Treatment extension benefits HCV genotype I patients without rapid virological response: a systematic review Netherlands journal of medicine 2011;69 (5):216-221 [PubMed]

2010

  • Kok Karin Francisca Alpha 1 antitrypsin deficiency: Focus on liver disease in young and old 2010. 131p. [UvA Dissertations Online] Radboud University Nijmegen. (Supervisor: Drenth J. P. H.; Co-supervisors: van Oijen M. G. H., de Vries R. A.)
  • van Boxel Ofke S., van Oijen Martijn G. H., Hagenaars Matthijs P., Smout A. J. P. M., Siersema Peter D. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study American journal of gastroenterology 2010;105 (11):2430-6; quiz 2437 [PubMed]
  • van Oijen Martijn G. H., Focks Jeroen Jaspers, Laheij Robert J. F. Comparison of Incident Dyspepsia Between Low-Dose Plain Aspirin and Enteric-Coated Aspirin Clinical gastroenterology and hepatology 2010;8 (4):395-395; author reply 396 [PubMed]
  • Tielemans Merel M., Eikendal Ties, Jansen Jan B. M. J., van Oijen Martijn G. H. Identification of NSAID Users at Risk for Gastrointestinal Complications A Systematic Review of Current Guidelines and Consensus Agreements Drug safety 2010;33 (6):443-453 [PubMed]
  • Kok Karin F., van Soest Hanneke, van Herwaarden Antonius E., van Oijen Martijn G. H., Boland Greet J., Halangk Juliane, Berg Thomas, de Vries Richard A., Drenth Joost P. H. Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy European journal of gastroenterology & hepatology 2010;22 (7):808-812 [PubMed]
  • van Oijen Martijn G. H. Klinische relevantie van retrospectieve observaties Nederlands tijdschrift voor geneeskunde 2010;154:A2174 [PubMed]
  • Kok Karin F., te Morsche René H., van Oijen Martijn G. H., Drenth Joost P. H. Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study BMC gastroenterology 2010;10:22 [PubMed]
  • de Vries Hilbert S., te Morsche Rene H. M., van Oijen Martijn G. H., Nagtegaal Iris D., Peters Wilbert H. M., de Jong Dirk J. The Functional-765G -> C Polymorphism of the COX-2 Gene May Reduce the Risk of Developing Crohn's Disease PLoS ONE 2010;5 (11):e15011 [PubMed]
  • Lamers Mieke M. H., van Oijen Martijn G. H., Pronk Martine, Drenth Joost P. H. Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials Journal of hepatology 2010;53 (1):191-198 [PubMed]

2009

  • Spiegel B. M. R., Farid M., van Oijen M. G. H., Laine L., Howden C. W., Esrailian E. Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers Alimentary pharmacology & therapeutics 2009;29 (8):871-881 [PubMed]
  • Waanders Esmé, van Keimpema Loes, Brouwer Johannes T., van Oijen Martijn G. H., Aerts Raymond, Sweep Fred C. G. J., Nevens Frederik, Drenth Joost P. H. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease Liver international 2009;29 (9):1389-1395 [PubMed]
  • Slavenburg S., Lamers M. H., Roomer R., de Knegt R. J., van Oijen M. G. H., Drenth J. P. H. Current clinical care compared with new Dutch guidelines for hepatitis C treatment Netherlands journal of medicine 2009;67 (5):177-181 [PubMed]
  • van Rossum L. G. M., van Rijn A. F., Laheij R. J. F., van Oijen M. G. H., Fockens P., Jansen J. B. M. J., Verbeek A. L. M., Dekker E. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme British journal of cancer 2009;101 (8):1274-1281 [PubMed]
  • Kristinsson Jón O., van Westerveld Paul, te Morsche Rene H. M., Roelofs Hennie M. J., Wobbes T., Witteman Ben J. M., Tan Adriaan C. I. T. L., van Oijen Martijn G. H., Jansen Jan B. M. J., Peters Wilbert H. M. Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma World journal of gastroenterology 2009;15 (28):3493-3497 [PubMed]
  • van Marrewijk Corine J., Mujakovic Suhreta, Fransen Gerdine A. J., Numans Mattijs E., de Wit Niek J., Muris Jean W. M., van Oijen Martijn G. H., Jansen Jan B. M. J., Grobbee Diederik E., Knottnerus J. André, Laheij Robert J. F. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H-2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial Lancet 2009;373 (9659):215-225 [PubMed]
  • van Oijen Martijn G. H., Barthélémy Christine, Janssen Marcel J. R., Joiris Etienne, Peters Wilbert H. M., Laheij Robert J. F., Smits Paul, Odou Pascal, Jansen Jan B. M. J. Effect of Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 (UGT1A6) on Acetylsalicylic Acid Metabolism in Healthy Female Volunteers Pharmacology 2009;83 (4):237-242 [PubMed]
  • van Rossum Leo G. M., van Rijn Anne F., van Oijen Martijn G. H., Fockens Paul, Laheij Robert J. F., Verbeek Andre L. M., Jansen Jan B. M. J., Dekker Evelien False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening International journal of cancer. Journal international du cancer 2009;125 (4):746-750 [PubMed]
  • Nguyen Thai V., Janssen Marcel J. R., van Oijen Martijn G. H., Bergevoet Saskia M., te Morsche Rene H. M., van Asten Henri, Laheij Robert J. F., Peters Wilbert H. M., Jansent Jan B. M. J. Genetic Polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and Gastric Cancer Risk in a Vietnamese Population Oncology research 2009;18 (7):349-355 [PubMed]
  • van Oijen Martijn G. H., Koetsier Marjolein I. A., Laheij Robert J. F., Roelofs Hennie M. J., te Morsche René H. M., Peters Wilbert H. M., Verheugt Freek W. A., Jansen Jan B. M. J., Drenth Joost P. H. Genetic polymorphisms in UDP-glucuronosyltransferase 1A6 are not associated with NSAIDs-related peptic ulcer haemorrhage Drug metabolism letters 2009;3 (3):199-204 [PubMed]
  • van Marrewijk C. J., van Oijen M. G. H., Paloheimo L. I., Fransen G. A. J., Mujakovic S., Muris J. W. M., Numans M. E., de Wit N. J., Grobbee D. E., Knottnerus J. A., Laheij R. J. F., Jansen J. B. M. J. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia Alimentary pharmacology & therapeutics 2009;30 (1):82-89 [PubMed]
  • van Keimpema Loes, Nevens Frederik, Vanslembrouck Ragna, van Oijen Martijn G. H., Hoffmann Aswin L., Dekker Helena M., de Man Robert A., Drenth Joost P. H. Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial Gastroenterology 2009;137 (5):1661-1668 [PubMed]
  • de Vries Hilbert S., van Oijen Martijn G. H., van Hoven-van Loo Karin E. J., de Jong Dirk J. Monitoring Vital Signs During Infusion With Infliximab Does Neither Indicate Nor Predict Development of Acute Infusion Reactions Journal of clinical gastroenterology 2009;43 (4):387-388 [PubMed]
  • Slavenburg Serena, Weggelaar Ines, van Oijen Martijn G. H., Drenth Joost P. H. Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis Antiviral therapy 2009;14 (8):1139-1148 [PubMed]
  • van Esch Aura A. J., Lamberts Mark P., te Morsche René H. M., van Oijen Martijn G. H., Jansen Jan B. M. J., Drenth Joost P. H. Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis BMC gastroenterology 2009;9:97 [PubMed]
  • de Vries Hilbert S., van Oijen Martijn G. H., de Jong Dirk J. Safety of Infliximab in Inflammatory Bowel Disease Needs to Be Debated Clinical gastroenterology and hepatology 2009;7 (5):603-604 [PubMed]
  • van Rossum Leo G. M., van Oijen Martijn G. H., Regula Jaroslaw Still No Meta-Analysis of Screening Colonoscopy for Colorectal Cancer? Digestive diseases and sciences 2009;54 (3):696-697 [PubMed]
  • Desai Amar A., Nissenson Allen, Chertow Glenn M., Farid Mary, Singh Inder, van Oijen Martijn G. H., Esrailian Eric, Solomon Matthew D., Spiegel Brennan M. R. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review Hemodialysis international. International Symposium on Home Hemodialysis 2009;13 (3):347-359 [PubMed]

2008

  • Slavenburg Serena, van Oijen Martijn G. H., Spiegel Brennan M. R. Comparison of health-related quality of life between populations Liver international 2008;28 (2):285-286 [PubMed]
  • van Rossum Leo G. M., van Oijen Martijn G. H., Jansen Jan B. M. J. Family History and Survival in Patients With Stage III Colorectal Cancer JAMA 2008;300 (17):1996-1996; author reply 1997 [PubMed]
  • van Kerkhoven L. A. S., Eikendal T., Laheij R. J. F., van Oijen M. G. H., Jansen J. B. M. J. Gastrointestinal symptoms are still common in a general Western population Netherlands journal of medicine 2008;66 (1):18-22 [PubMed]
  • van Oijen Martijn G. H., Dieleman Jeanne P., Laheij Robert J. F., Sturkenboom Miriam C. J. M., Jansen Jan B. M. J., Verheugt Freek W. A. Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin Clinical gastroenterology and hepatology 2008;6 (3):309-313 [PubMed]
  • van Oijen Martijn G. H., Claessen Bimmer E. P. M., Clappers Nick, van Schaik Annie, Laheij Robert J. F., Jansen Jan B. M. J., Peters Wilbert H. M., Verheugt Freek W. A. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome American journal of cardiology 2008;102 (2):135-139 [PubMed]
  • van Soest Eva M., van Rossum Leo G. M., Dieleman Jeanne P., van Oijen Martijn G. H., Siersema Peter D., Sturkenboom Miriam C. J. M., Kuipers Ernst J. Proton pump inhibitors and the risk of colorectal cancer American journal of gastroenterology 2008;103 (4):966-973 [PubMed]
  • van Rossum Leo G., van Rijn Anne F., Laheij Robert J., van Oijen Martijn G., Fockens Paul, van Krieken Han H., Verbeek Andre L., Jansen Jan B., Dekker Evelien Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 2008;135 (1):82-90 [PubMed]
  • de Vries Hilbert S., van Oijen Martijn G. H., de Jong Dirk J. Serious Events with Infliximab in Patients with Inflammatory Bowel Disease A 9-Year Cohort Study in the Netherlands Drug safety 2008;31 (12):1135-1144 [PubMed]
  • Clappers Nick, van Oijen Martijn G. H., Sundaresan Santosh, Brouwer Marc A., te Morsche Rene H. M., Keuper Wessel, Peters Wilbert H. M., Drenth Joost P. H., Verheugt Freek W. A. The C50T polymorphism of the cyclooxygenase-I gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid Thrombosis and haemostasis 2008;100 (1):70-75 [PubMed]

2007

  • Berends Maartje A. M., Snoek Josje, de Jong Elke M. G. J., van Krieken J. Han, de Knegt Robert J., van Oijen Martijn G. H., van de Kerkhof Peter C. M., Drenth Joost P. H. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan((R)) predicts the absence of significant liver fibrosis Liver international 2007;27 (5):639-645 [PubMed]
  • van Oijen Martijn G. H., Sipponen Pentti, Laheij Robert J. F., Verheugt Freek W. A., Jansen Jan B. M. J. Gastric status and vitamin B12 levels in cardiovascular patients Digestive diseases and sciences 2007;52 (9):2186-2189 [PubMed]
  • van Oijen Martijn G. H., Vlemmix Floor, Laheij Robert J. F., Paloheimo Lea, Jansen Jan B. M. J., Verheugt Freek W. A. Hyperhomocysteinaemia and vitamin B12 deficiency: The long-term effects in cardiovascular disease Cardiology 2007;107 (1):57-62 [PubMed]
  • van Oijen Martijn G. H., Laheij Robert J. F. Impact of CYP2C9 genotype on pharmacokinetics: Are all NSAIDs the same? Gastroenterology 2007;133 (6):2073-2074 [PubMed]
  • Berends Maartje A. M., van Oijen Martijn G. H., Snoek Josje, van de Kerkhof Peter C. M., Drenth Joost P. H., Han van Krieken J., de Jong Elke M. G. J. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis Archives of dermatology 2007;143 (12):1515-1519 [PubMed]
  • van Oijen M. G. H., Laheij R. J. F., Jansen J. B. M. J., Verheugt F. W. A. The predictive value of vitamin B12 concentrations and hyperhomocysteinaemia for cardiovascular disease Netherlands heart journal 2007;15 (9):291-294 [PubMed]

2006

  • van Kerkhoven Lieke A. S., van Rossum Leo G. M., van Oijen Martijn G. H., Tan Adriaan C. I. T. L., Witteman Ellen M., Laheij Robert J. F., Jansen Jan B. M. J. Alexithymia is associated with gastrointestinal symptoms, but does not predict endoscopy outcome in patients with gastrointestinal symptoms Journal of clinical gastroenterology 2006;40 (3):195-199 [PubMed]
  • van Oijen Martijn G. H., Laheij Robert J. F., Koetsier Marjolein, de Kleine Evelien, te Morsche René H. M., van Kerkhoven Lieke A. S., Jansen Jan B. M. J., Drenth Joost P. H. Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage Digestive diseases and sciences 2006;51 (12):2348-2352 [PubMed]
  • Bovenschen H. J., Janssen M. J. R., van Oijen M. G. H., Laheij R. J. F., van Rossum L. G. M., Jansen J. B. M. J. Evaluation of a gastrointestinal symptoms questionnaire Digestive diseases and sciences 2006;51 (9):1509-1515 [PubMed]
  • van Oijen M. G. H., Josemanders D. F. G. M., Laheij R. J. F., van Rossum L. G. M., Tan A. C. I. T. L., Jansen J. B. M. J. Gastrointestinal disorders and symptoms: does body mass index matter? Netherlands journal of medicine 2006;64 (2):45-49 [PubMed]
  • Berends M. A. M., Snoek J., de Jong E. M. G. J., van de Kerkhof P. C. M., van Oijen M. G. H., van Krieken J. H., Drenth J. P. H. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent Alimentary pharmacology & therapeutics 2006;24 (5):805-811 [PubMed]
  • van Kerkhoven L. A., van Rossum L. G., van Oijen M. G., Tan A. C., Laheij R. J., Jansen J. B. Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia Endoscopy 2006;38 (9):879-885 [PubMed]
  • Nguyen T. V., van Oijen M. G. H., Janssen M. J. R., Laheij R. J. F., Jansen J. B. M. J., van Asten H. Vitamin B12 deficiency in patients with upper gastrointestinal symptoms in the Mekong Delta, Vietnam Digestive and liver disease 2006;38 (6):438-439 [PubMed]

2005

  • van Kerkhoven L. A. S., van Rossum L. G. M., van Oijen M. G. H., Witteman E. M., Jansen J. B. M. J., Laheij R. J. F., Tan A. C. I. T. L. Anxiety, depression and psychotropic medication use in patients with persistent upper and lower gastrointestinal symptoms Alimentary pharmacology & therapeutics 2005;21 (8):1001-1006 [PubMed]
  • van Oijen Martijn G. H., Huybers Sylvie, Peters Wilbert H. M., Drenth Joost P. H., Laheij Robert J. F., Verheugt Freek W. A., Jansen Jan B. M. J. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid British journal of clinical pharmacology 2005;60 (6):623-628 [PubMed]

2004

  • van Oijen Martijn G. H., Laheij Robert J. F., Peters Wilbert H. M., Jansen Jan B. M. J., Verheugt Freek W. A. Association of aspirin use with vitamin B-12 deficiency (Results of the BACH Study American journal of cardiology 2004;94 (7):975-+ [PubMed]
  • Laheij R. J. E., Verlaan M., van Oijen M. G. H., de Doelder M. S., Dejong C. A. J., Jansen J. B. M. J. Gastrointestinal symptoms and ethanol metabolism in alcoholics Digestive diseases and sciences 2004;49 (6):1007-1011 [PubMed]
  • van Oijen Martijn G. H., Laheij Robert J. F., de Jong Cor A. J., Peters Wilbert H. M., Jansen Jan B. M. J. Vitamin B12 status and its association with Helicobacter pylori infection in alcohol dependent patients Journal of nutritional science and vitaminology 2004;50 (5):305-308 [PubMed]